| Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304) |
|---|
| 06/20/2013 | WO2013090591A1 Process for preparing alkyl pyroglutamic acids |
| 06/20/2013 | WO2013089152A1 Lipid nanoparticles containing combinations of cationic lipids |
| 06/20/2013 | WO2013087954A1 Compounds that inhibit beta amyloid peptide aggregation |
| 06/20/2013 | WO2013087934A1 Cationic para-phenylenediamines, composition comprising at least such compounds, implementation process therefor and use thereof |
| 06/20/2013 | US20130158275 New process for the preparation of intermediates useful for the manufacture nep inhibitors |
| 06/20/2013 | US20130158070 Conjugates of polyunsaturated fatty acids and amine-containing compounds and uses thereof |
| 06/20/2013 | US20130157339 Stabilized protease composition |
| 06/19/2013 | EP2604592A1 A process for the purification of aniracetam by crystallisation from aqueous solutions |
| 06/19/2013 | EP2603487A1 Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 06/19/2013 | CN103168028A Cyclic amide derivative |
| 06/19/2013 | CN103159663A Method for preparing pyrrole derivative from divinyl derivative |
| 06/19/2013 | CN103159662A Method for preparing pyrrole derivative with sulfonyl group on beta-substituent |
| 06/19/2013 | CN103159661A Preparation method of levetiracetam |
| 06/19/2013 | CN103159660A (2R)-1-(2-methyl-3-(methoxy(methyl)amino)-propionyl)pyrrolidine-2-carboxylic acid and application thereof |
| 06/19/2013 | CN103159659A Preparation method of muscarinic receptor antagonist glycopyrronium bromide |
| 06/19/2013 | CN102199154B Novel synthesis method for pyrrole derivatives |
| 06/19/2013 | CN101405259B Process for production of ethylenediamine derivative having halogenated carbamate group and acyl group, and intermediated for production of the derivative |
| 06/18/2013 | US8466297 Manufacturing process for (S)-Pregabalin |
| 06/18/2013 | US8466185 Methods and assays for detecting and treating hypoglycemia |
| 06/18/2013 | US8466182 Small molecule inhibitors of kynurenine-3-monooxygenase |
| 06/13/2013 | WO2013084013A1 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists |
| 06/13/2013 | WO2013083975A2 Novel pyrrole derivatives |
| 06/13/2013 | WO2013083326A1 New process and intermediates for the synthesis of vildagliptin |
| 06/13/2013 | US20130150591 Method for purifying n-alkyl-substituted pyrrolidones by hydrogenation |
| 06/13/2013 | US20130150572 Phosphinate ruthenium complexes |
| 06/13/2013 | US20130150424 Proline sulfonamide derivatives as orexin receptor antagonists |
| 06/13/2013 | US20130150416 Glutamate receptor modulators and therapeutic agents |
| 06/13/2013 | US20130150374 Arylalkylamine compound and process for preparing the same |
| 06/13/2013 | US20130150367 Carboxamide compounds and their use as calpain inhibitors |
| 06/13/2013 | US20130150281 Polymeric prodrug with self-immolative linker |
| 06/13/2013 | CA2857198A1 Cycloalkane carboxylic acid derivatives as cxcr3 receptor antagonists |
| 06/13/2013 | CA2855351A1 Novel pyrrole derivatives |
| 06/12/2013 | EP2602248A1 Novel pyrrole compounds |
| 06/12/2013 | EP2602247A1 Method for purifying N-alkyl substituted pyrrolidones through hydration |
| 06/12/2013 | EP2602246A1 Method for purifying N-alkyl substituted pyrrolidones |
| 06/12/2013 | EP2602244A1 (Meth) Acrylic acid ester, activation energy ray curing composition, and inkjet recording ink |
| 06/12/2013 | EP2601950A1 Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists |
| 06/12/2013 | EP2601840A2 Chemical and biological agents for the control of molluscs |
| 06/12/2013 | EP2600860A1 Substituted 2-hydroxy-4-(2-(phenylsulfonamido)acetamido)benzoic acid analogs as inhibitors of stat proteins |
| 06/12/2013 | CN103153951A Pyrrolidinones as MetAP-2 inhibitors |
| 06/12/2013 | CN103153950A Serotonin reuptake inhibitors |
| 06/12/2013 | CN103153949A Insecticidal pyrrolidin-yl-aryl-carboxamides |
| 06/12/2013 | CN103153917A Thionation process and thionating agent |
| 06/12/2013 | CN103145601A Preparation method of N-hydroxysuccinimide |
| 06/12/2013 | CN103145600A Synthesis method of silver-catalyzed polysubstitued pyrrole compounds |
| 06/12/2013 | CN103145599A Method for purifying n-alkyl substituted pyrrolidones through hydration |
| 06/12/2013 | CN103145598A Oxaceprol crystal and composition comprising same |
| 06/12/2013 | CN102249977B 4-hydroxy-2-oxo-1-pyrrolidine acetamide racemate crystal I and preparation method thereof |
| 06/12/2013 | CN102174007B Industrial preparation method of [2-(2-cyano-pyrrolidine-1-yl)-2-oxo-ethyl]-tert-butyl carbamate |
| 06/12/2013 | CN101754951B Method for preparing FMOC-based hydrolysable linkers |
| 06/12/2013 | CN101273013B Sulfonamide derivative having PGD2 receptor antagonistic activity |
| 06/11/2013 | US8461332 Method for producing curing agent having acidic substituent and unsaturated maleimide group, thermosetting resin composition, prepreg, and laminate |
| 06/11/2013 | CA2683826C Pentacyclic anion salts or tetrazapentalene derivatives and their uses as ionic conducting materials |
| 06/11/2013 | CA2577837C Diarylsulfones as 5-ht2a antagonists |
| 06/11/2013 | CA2546101C N-acylsulfonamide apoptosis promoters |
| 06/06/2013 | WO2013079223A1 Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rorϒ, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases |
| 06/06/2013 | US20130144070 Processes for the production of pyrrolidones |
| 06/06/2013 | US20130143926 Benzamide derivatives and their use as hsp90 inhibtors |
| 06/06/2013 | US20130143858 Compounds and their use as ikach blockers |
| 06/06/2013 | US20130142758 Novel hydroxamates as therapeutic agents |
| 06/06/2013 | CA2856946A1 Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rory, nr1f3) activity and for the treatment of chronic inflammatory and autoimmunediseases |
| 06/05/2013 | CN202968432U Bismaleimide production device |
| 06/05/2013 | CN103140905A Electrolyte formulations |
| 06/05/2013 | CN103130701A N-acryloyl group sulfo-group succinimide and preparation method thereof |
| 06/05/2013 | CN103130595A Method for hydrolyzing feather to extract amino acid through microwave heating at high temperature and high pressure |
| 06/05/2013 | CN102114430B Catalyst and preparation method thereof as well as method for preparing N-alkylpyrrole derivatives |
| 06/05/2013 | CN102101855B Preparation method of atorvastatin calcium isomer mixture and its intermediate |
| 06/05/2013 | CN101133060B Enzyme inhibitors |
| 06/04/2013 | US8455665 3-phenoxymethylpyrrolidine compounds |
| 06/04/2013 | US8455660 1-(sulfonyl)-N-phenylpyrrolidine-2-carboxamides for the identification of biological and pharmacological activity |
| 06/04/2013 | US8455646 Alkaloid aminoester derivatives and medicinal composition thereof |
| 06/04/2013 | US8455498 Inhibitors of histone deacetylase |
| 06/04/2013 | US8455222 Biliverdin from a non-animal source |
| 05/30/2013 | WO2013076063A1 Novel pyrrolidine derivatives as inhibitors of cathepsin |
| 05/30/2013 | WO2013075630A1 Nano particles of nucleic acid and preparation process and use thereof, and three-head single chain nucleic acid unit |
| 05/30/2013 | WO2013049280A3 Sphingosine analogs, compositions, and methods related thereto |
| 05/30/2013 | US20130137852 Novel compounds as dpp-iv inhibitors and process for preparation thereof |
| 05/30/2013 | US20130137746 Indane estrogen receptor modulators and uses thereof |
| 05/30/2013 | US20130137744 Pyrrolidine triple reuptake inhibitors |
| 05/30/2013 | US20130137687 Novel pyrrolidine derivatives |
| 05/30/2013 | US20130136794 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof |
| 05/30/2013 | CA2854569A1 Novel pyrrolidine derivatives as inhibitors of cathepsin |
| 05/29/2013 | EP2596785A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 05/29/2013 | EP2596066A1 Dye compound, method of producing dipyrromethene metal complex compound, method of producing dye multimer, substituted pyrrole compound, colored curable composition, color filter, method of producing color filter, solid-state image sensor and liquid crystal display device |
| 05/29/2013 | EP2595975A2 Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex |
| 05/29/2013 | EP2595620A2 Benzenesulfonamide-compound treatment of a pathological condition linked to an excessive effect of tnf |
| 05/29/2013 | CN103124722A Method for producing amino acid amide derivative having fluorine-containing carbamate group, production intermediate thereof, and method for producing ethylene diamine derivative |
| 05/29/2013 | CN103121995A 3-alkyl-5- (4-alkyl-5-oxo-tetrahydrofutran-2-yl) pyrrolidin-2-one derivatives as intermediates in the synthesis of renin inhibitors |
| 05/29/2013 | CN103121964A Method for preparing atorvastatin calcium key intermediate |
| 05/29/2013 | CN103121959A Compound, nucleic acid compound molecules and nucleic acid complex as well as preparation methods and application thereof |
| 05/29/2013 | CN101466710B Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| 05/28/2013 | US8450500 Pyrrole compounds that modulate HSP90 activity |
| 05/28/2013 | US8450362 Amidine-containing compounds useful as muscarinic receptor antagonists |
| 05/28/2013 | CA2648236C Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/28/2013 | CA2565630C Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 05/28/2013 | CA2562160C Cyanopyrrole containing cyclic carbamate and thiocarbamate biaryls and methods for preparing the same |
| 05/28/2013 | CA2561897C Thio-substituted biaryl-methanesulfinyl derivatives |
| 05/28/2013 | CA2539823C Hemiasterlin derivatives and uses thereof |
| 05/28/2013 | CA2508621C Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 05/23/2013 | WO2013073525A1 Industrial method for producing optically active 3-cyclopropylaminomethyl-4-fluoropyrrolidines |